Duke University Hospital · Decision guide

Duke University Hospital: heart surgery expertise

Durham, North Carolina, United States · Aortic reconstruction, transplantation and mechanical support

Research by Yevhenii Kozlov · Co-Founder of BookimedUpdated 8 October 2026Sources linked throughout

At a glance

Duke combines cardiac and vascular aortic expertise with an advanced heart-failure service. Hughes’s team covers the root through the thoraco-abdominal aorta; Schroder’s surgical remit includes transplantation, LVAD, ECMO and total artificial heart.

Aortic continuity of care

The centre describes imaging, genetics and lifelong surveillance alongside open and endovascular treatment.

Sources: Duke Center for Aortic Disease combines cardiothoracic and vascular surgery · G. Chad Hughes, MD

Repair durability is technique-specific

In 71 HAART-ring repairs, 11 patients developed at least moderate leakage at mean 3.9-year follow-up; all had trileaflet valves.

Sources: Mid-term outcomes of aortic valve repair using an anatomically shaped internal annuloplasty ring.

Support and transplant pathways

Duke’s advanced heart-failure surgery service includes durable LVAD, temporary ECMO, total artificial heart and transplantation.

Sources: Jacob N. Schroder named Surgical Director for Advanced Heart Failure

Entrance of Duke University Hospital
Duke University Hospital entrance, from Duke Health’s official hospital-location image. · Image source ↗
Get a treatment proposal

Your diagnosis, selected specialist and treatment priorities.

Clinical benefits and limitations

Specialists and their clinical work

Durham, North Carolina · United States

cardiac surgeon

Jacob N. Schroder →

Jacob Schroder leads surgical advanced heart-failure care at Duke. His remit connects heart transplantation with durable LVADs, temporary ECMO and total artificial-heart care, addressing different degrees and durations of circulatory support.

Sources: Jacob N. Schroder named Surgical Director for Advanced Heart Failure · Transplantation Outcomes with Donor Hearts after Circulatory Death.

Procedure-specific research

Read alongside G. Chad Hughes’s profile →

A study that reported a durability concern

Hughes coauthored a 71-patient HAART-ring repair series. At mean follow-up of 3.9 years, 11 patients had at least moderate regurgitation, all with trileaflet valves; four needed reoperation, including three for ring dehiscence.

How to interpret this: The authors urged caution with this subannular approach in trileaflet valves. This device-specific cohort should not be generalized to all Duke aortic surgery or all valve-sparing techniques; it is not an individual risk estimate.

Sources: Mid-term outcomes of aortic valve repair using an anatomically shaped internal annuloplasty ring.

Read alongside Jacob N. Schroder’s profile →

DCD trial: what was established

The 2023 multicentre randomized trial led by Schroder met its noninferiority endpoint for risk-adjusted survival six months after transplantation using the studied DCD/perfusion pathway.

How to interpret this: Primary analysis was as treated. Selected donors, recipients and equipment limit generalization; this is not a personal survival rate, universal eligibility rule or long-term equivalence claim.

Sources: Transplantation Outcomes with Donor Hearts after Circulatory Death.

Continue your guide

Related heart surgery guides

Turn information into your next step.

Free Bookimed support. Compare options before deciding.

Get a treatment proposal
Get a treatment proposal

Your diagnosis, selected specialist and treatment priorities.